2 funding - 287,900€

data available since 2022

2022

  1. Early Markers of Disease In Hypertrophic Cardiomyopathy

    euro 57,000.00

  2. Genetic Modulators of Phenotypic Expression of Hypertrophic Cardiomyopathy

    euro 230,900.00